Upcoming Allied Market Research
Cancer Profiling And Pathways Market

Cancer Profiling and Pathways Market

Size, Share, Competitive Landscape and Trend Analysis Report by Technology (Next-generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Immunohistochemistry (IHC), In Situ Hybridization (ISH), Microarray, Others), by Technique (Genomics, Proteomics, Epigenetics, Metabolomics), by Application (Personalized Medicine, Diagnostics, Biomarker Discovery, Prognostics, Research Applications) and by End User (Hospitals, Ambulatory Surgical Centers, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

Report Code: A13856
Pages: NA
Tables: NA
Charts: NA
  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.


Cancer profiling is an approach for more correctly classifying cancers and predicting a patient's clinical outcomes. Cancer/tumor profiling aids in the discovery of genetic alterations, which assists in the selection of appropriate cancer therapy. This technique eliminates the need for trial-and-error in cancer diagnosis at various stages and provides more precise and reliable information regarding cancer clinical outcomes.
Different procedures are used to diagnose cancer, including blood and urine tests, biopsy, imaging tests (X-ray, MRI, PET/CT, and ultrasound), nuclear medicine scans, and lumber puncture, which are unable to pinpoint the exact cause of cancer in the early stages. Overtreatment of cancer patients may result as a result of this. To provide better, customized treatment to the cancer patient, laboratory tests are performed to detect specific genes or gene mutations, proteins, or other biomarkers in a sample of tumor tissue.

COVID-19 Impact analysis

  • The COVID-19 pandemic is not predicted to have a substantial impact on cancer/tumor profiling market. There has been a considerable decline in cancer testing and detection due to COVID-19 related measures. However, because several of the COVID-19 patients had cancer, cancer has been recognized as a risk factor for COVID-19. Further study is being conducted in this area to better understand the dynamics of infection, which is likely to advance the cancer research field.
  • On the other hand, researchers expect the majority of cancer diagnostic and prognostic tests, as well as tailored therapy, will rise at a steady rate over the forecasted years. Surgery, radiation therapy, and chemotherapy rounds have all been postponed significantly. As a result, by the first quarter of 2021, cancer surgery, radiation therapy, and chemotherapy sessions should have reached 2019 levels.

Top Impacting Factors
Rise in the incidence of cancer, population growth, and aging, as well as the changes in prevalence of certain causes of cancer linked to social and economic development, are the factors propelling cancer/tumor profiling market.
In addition, increased demand for personalized medicine and next-generation sequencing (NGS) technology is also expected to boost the growth of the Cancer Profiling and Pathways market. 
Moreover, government funding for continuing research in tumor or cancer diagnostics and profiling is another major factor driving the growth of the market.
The rise in the adoption of cancer profiling methods by oncologists as well as an increase in the use of biomarkers in cancer profiling is projected to surge the Cancer Profiling and Pathways market growth.
An increase in the demand for next-generation sequencing techniques in cancer profiling is expected to boost the Cancer Profiling and Pathways market growth. 
However, the large gap between the biomarker discovery stage and their clinical conversion is being hindered by challenges in conversion procedures.

Market Trends
New product launches to flourish the market

  • In 2020, Illumina’s COVID response: Illumina partnered with IDbyDNA Partner to deliver NGS Infectious Disease solutions. The partnership aims to accelerate NGS’ adoption of clinical infectious disease testing. This partnership also aims to make next-generation software with powerful bioinformatics software that can turn data into actionable insights.
  • In January 2021, Illumina announced an oncology collaboration with Kura Oncology, Bristol Myers Squibb, Merck and Myriad Genetics to boost genomic profiling. The collaboration will help them develop standardized and distributable tools for precision oncology.
  • In May 2019, NeoGenomics Laboratories collaborated with QIAGEN to offer companion diagnostic test for HR+/HER2 for advanced breast cancer patients to detect PIK3CA mutation using QIAGEN’s therascreen PIK3CA RGQ PCR test.

Key Benefits of the Report

  • This study presents the analytical depiction of the Cancer Profiling and Pathways along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the Cancer Profiling and Pathways market share.
  • The current market is quantitatively analyzed to highlight the Cancer Profiling and Pathways market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market. 
  • The report provides a detailed analysis based on competitive intensity and how the competition will take shape in coming years.

Questions answered in the Cancer Profiling and Pathways Report

  • Who are the leading market players active in the Cancer Profiling and Pathways market?
  • What current trends will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities in the market?
  • What future projections would help in taking further strategic steps?
  • What is "Cancer Profiling and Pathways"?
  • What is "Cancer Profiling and Pathways" Market prediction in the future?
  • Who are the leading global players in the "Cancer Profiling and Pathways" Market?
  • What are the current trends and predicted trends?
  • What are the key benefits of the "Cancer Profiling and Pathways" Market report?

Cancer Profiling and Pathways Market Report Highlights

Aspects Details
By Technology
  • Next-generation Sequencing (NGS)
  • Polymerase Chain Reaction (PCR)
  • Immunohistochemistry (IHC)
  • In Situ Hybridization (ISH)
    • Fluorescence In Situ Hybridization (FISH)
    • Chromogenic In Situ Hybridization (CISH)
  • Microarray
  • Others
By Technique
  • Genomics
  • Proteomics
  • Epigenetics
  • Metabolomics
By Application
  • Personalized Medicine
  • Diagnostics
  • Biomarker Discovery
  • Prognostics
  • Research Applications
By End User
  • Hospitals
  • Ambulatory Surgical Centers
  • Others
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (Germany, France, UK, Italy, Spain, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
Key Market Players Neogenomics Inc., Qiagen N.V., Illumina Inc, Oxford Gene Technology, Foundation Medicine., GenomeDX, Nanostring Technologies, Ribomed Biotechnologies Inc., Guardant Health, Genomic Health

Loading Table Of Content...

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

Purchase Options

Call or Email Us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now
Related Tags

Purchase Full Report of
Cancer Profiling And Pathways Market

Start reading.
This Report and over 71,321+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,690
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,930
  • Restricted to one authorized user
  • One print only
  • Available in
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,820
  • Restricted to one authorized user
  • One print only
  • Available in
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,540
  • Limited to five authorized users
  • Print upto five copies
  • Available in
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Enterprise

  • $9,870
  • Unlimited
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Library

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
  • Company Profiles
  • Newly Added Content Access
  • 10 PDF
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

Related Reports

Why Allied Market Research?


Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of the scope of the report to exactly meet your needs

Targeted Market View

Targeted market view to provide pertinent information and save time for readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of the scope of the report to exactly meet your needs


Targeted market view to provide pertinent information and save the time of readers